Search research articles
Contact Us
Filters
Showing results (1-10 of 391) with videos related to
Page
of 40
Sort By:
Clinical Endocrinology
|
October 9, 2001
Are patients with acromegaly at high risk for dysrhythmias?
A Colao
Journal of Endocrinological Investigation
|
February 6, 2008
The manifesto A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) study group one year later: what to keep and what to amend?
A Colao, E Ghigo,
Journal of Endocrinological Investigation
|
February 27, 2003
The diagnosis of secondary adrenal insufficiency: low dose vs high dose ACTH stimulation test
A Colao, R Pivonello
Journal of Endocrinological Investigation
|
March 30, 2010
Dose optimization of somatostatin analogues for acromegaly patients
A Colao, G Lombardi
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1997
Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy
A Colao, G Lombardi
Lancet (London, England)
|
November 10, 1998
Growth-hormone and prolactin excess
A Colao, G Lombardi
European Journal of Endocrinology
|
April 7, 2007
The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas
A Colao, L J Hofland
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
August 14, 2003
Future direction in acromegaly - redefining control
S M Webb, A Colao
Annals of Medicine
|
November 14, 1998
Treatment of prolactinomas
A Colao, L Annunziato, G Lombardi
Expert Opinion on Pharmacotherapy
|
March 16, 2001
Cabergoline
A Colao, G Lombardi, L Annunziato
Page
of 40
Search research articles
Search
Showing results (1-10 of 391) with videos related to
Sort By:
Page
of 40
Clinical Endocrinology
|
October 9, 2001
Are patients with acromegaly at high risk for dysrhythmias?
A Colao
Journal of Endocrinological Investigation
|
February 6, 2008
The manifesto A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) study group one year later: what to keep and what to amend?
A Colao, E Ghigo,
Journal of Endocrinological Investigation
|
February 27, 2003
The diagnosis of secondary adrenal insufficiency: low dose vs high dose ACTH stimulation test
A Colao, R Pivonello
Journal of Endocrinological Investigation
|
March 30, 2010
Dose optimization of somatostatin analogues for acromegaly patients
A Colao, G Lombardi
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1997
Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy
A Colao, G Lombardi
Lancet (London, England)
|
November 10, 1998
Growth-hormone and prolactin excess
A Colao, G Lombardi
European Journal of Endocrinology
|
April 7, 2007
The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas
A Colao, L J Hofland
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
August 14, 2003
Future direction in acromegaly - redefining control
S M Webb, A Colao
Annals of Medicine
|
November 14, 1998
Treatment of prolactinomas
A Colao, L Annunziato, G Lombardi
Expert Opinion on Pharmacotherapy
|
March 16, 2001
Cabergoline
A Colao, G Lombardi, L Annunziato
Page
of 40